EMI-137

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameEMI-137
Drug Alias NameEMI-137GE-137
ClassificationDiagnostic agent (In vivo)Small molecules > Heterocyclic drugs
Mechanisms of ActionDiagnostic imaging enhancers
TargetsHepatocyte growth factor receptor
Therapy Area/IndicationsBarrett EsophagusExtranodal ExtensionColonic Neoplasms +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlandsUnited Kingdom
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGe Healthcare
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsBarrett EsophagusExtranodal ExtensionColonic Neoplasms +[4

Other Information

ATC CodeN/A
Related LinksN/A